Published in

Nature Research, Nature Medicine, 2(27), p. 279-288, 2020

DOI: 10.1038/s41591-020-01179-4

Links

Tools

Export citation

Search in Google Scholar

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.

Journal article published in 2020 by Rebecca te Water Naude, Terri Wrin, Xin Li Yao, Dalila Zizi, Barrett Jr, Jordan R. Barrett ORCID, Ingrid Cabrera Puig, Sandra Belij Rammerstorfer, Ewer Kj, Xinxue Liu, Christina Dold ORCID, , Katie J. Ewer, Stephen Taylor, Pedro M. Folegatti ORCID and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO